Why the study?
To examine the effectiveness of adding L-arginine to the treatment regimen of patients with hypertonic disease accompanied by insulin resistance.
Does adding L-arginine to standard antihypertensive and hypolipidemic therapy improve endothelium dependent vasodilatation, HOMA-index, and hypertriglyceridemia in patients with hypertension and insulin resistance?
Cohort (n=37)
No
Does adding L-arginine to standard antihypertensive and hypolipidemic therapy improve endothelium dependent vasodilatation, HOMA-index, and hypertriglyceridemia in patients with hypertension and insulin resistance?
Adding L-arginine to standard therapy in patients with hypertension and insulin resistance may improve endothelial function and metabolic parameters.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Taschuk et al. (2019) conducted a cohort in Arterial hypertension with insulin resistance (n=37). L-arginine vs. Standard therapy (lisinopril, amlodipine, atorvastatin) was evaluated on Endothelium-dependent vasodilation (EDVD) dynamics (p=0.036).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: